HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Reduced expression of Breast Cancer 1, early onset (BRCA1) is common in sporadic breast tumors without genetic mutations.
• The molecular mechanisms underlying this downregulation remain unclear.

Purpose of the Study:

• To identify genes involved in sporadic breast cancer and elucidate their role in BRCA1 regulation.
• To investigate the function of homeobox A9 (HOXA9) in breast tumor suppression.

Main Methods:

• Gene expression analysis in human breast cancers and cell lines.
• In vitro studies on mammary epithelial cell growth, survival, and morphogenesis.
• In vivo xenograft mouse models.
• Molecular studies on HOXA9-BRCA1 interactions.

Main Results:

• HOXA9 was frequently downregulated in breast cancers, with lower levels correlating with tumor aggression, metastasis, and mortality.
• Loss of HOXA9 promoted mammary cell growth and survival, while its restoration inhibited tumor progression.
• HOXA9 directly modulated BRCA1 expression, and BRCA1 mimicked HOXA9's tumor-suppressive effects.
• HOXA9 expression correlated with BRCA1 levels and inversely with tumor aggression in specific patient cohorts.

Conclusions:

• HOXA9 acts as a tumor suppressor in breast cancer by modulating BRCA1 expression.
• This mechanism explains the reduced BRCA1 expression observed in sporadic breast tumors.
• HOXA9 represents a potential therapeutic target for breast cancer treatment.